Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TIVA in pediatric cleft palate surgery
PACTR201710002426237Not yet recruiting
- Sponsor
- Tanta University Hospitals
- Start
- Jun 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Trial of propofol + remifentanil in cleft palate (2 arms), sponsored by Tanta University Hospitals. Primary endpoint: Smooth recovery without complications. Planned start Jun 2017; status: not yet recruiting.
02
Drugs
propofol + remifentanil
03
Conditions
cleft palate
Beyond the preview
Go deeper on PACTR201710002426237.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201710002426237.